Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperdal Consta versus oral atypical antipsychotics in poorly adherent patients with schizophrenia
2005-004383-23Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of risperidone, olanzapine, quetiapine, aripiprazole and amisulpride in schizophrenia (2 arms), sponsored by Janssen Pharmaceutical. Started Oct 2005; status: completed.
02
Drugs
risperidoneolanzapinequetiapinearipiprazoleamisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2005-004383-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004383-23.